Diabetes & Metabolism Journal

Mitochondrial Dysfunction in Adipocytes as a Primary Cause of Adipose Tissue Inflammation: Chang-Yun Woo, Jung Eun Jang, Seung Eun Lee, Eun Hee Koh, Ki-Up Lee; Diabetes Metab J. 2019;43(3):247-256. Published online March 27, 2019; DOI: https://doi.org/10.4093/dmj.2018.0221
Cited By 52; Full text PubReader Crossref - TDM PDF

Understanding Bile Acid Signaling in Diabetes: From Pathophysiology to Therapeutic Targets: Jessica M. Ferrell, John Y. L. Chiang; Diabetes Metab J. 2019;43(3):257-272. Published online June 13, 2019; DOI: https://doi.org/10.4093/dmj.2019.0043
Cited By 54; Full text PubReader Crossref - TDM PDF

Diabetes Mellitus, Still Major Threat to Mortality from Various Causes: Nam Hoon Kim; Diabetes Metab J. 2019;43(3):273-275. Published online June 13, 2019; DOI: https://doi.org/10.4093/dmj.2018.0102
Cited By 4; Full text PubReader Crossref - TDM PDF

Efficacy and Safety of Voglibose Plus Metformin in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial: Tae Jung Oh, Jae Myung Yu, Kyung Wan Min, Hyun Shik Son, Moon Kyu Lee, Kun Ho Yoon, Young Duk Song, Joong Yeol Park, In Kyung Jeong, Bong Soo Cha, Yong Seong Kim, Sei Hyun Baik, In Joo Kim, Doo Man Kim, Sung Rae Kim, Kwan Woo Lee, Jeong Hyung Park, In Kyu Lee, Tae Sun Park, Sung Hee Choi, Sung Woo Park; Diabetes Metab J. 2019;43(3):276-286. Published online December 7, 2018; DOI: https://doi.org/10.4093/dmj.2018.0051
Cited By 10; Full text PubReader Crossref - TDM PDF

Acarbose Add-on Therapy in Patients with Type 2 Diabetes Mellitus with Metformin and Sitagliptin Failure: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study: Hae Kyung Yang, Seung-Hwan Lee, Juyoung Shin, Yoon-Hee Choi, Yu-Bae Ahn, Byung-Wan Lee, Eun Jung Rhee, Kyung Wan Min, Kun-Ho Yoon; Diabetes Metab J. 2019;43(3):287-301. Published online December 20, 2018; DOI: https://doi.org/10.4093/dmj.2018.0054
Cited By 7; Full text PubReader Crossref - TDM PDF Supplementary Material

Effectiveness of Exercise Intervention in Reducing Body Weight and Glycosylated Hemoglobin Levels in Patients with Type 2 Diabetes Mellitus in Korea: A Systematic Review and Meta-Analysis: Ji-Eun Jang, Yongin Cho, Byung Wan Lee, Ein-Soon Shin, Sun Hee Lee; Diabetes Metab J. 2019;43(3):302-318. Published online November 19, 2018; DOI: https://doi.org/10.4093/dmj.2018.0062
Cited By 9; Full text PubReader Crossref - TDM PDF Supplementary Material

Diabetes Mellitus and Cause-Specific Mortality: A Population-Based Study: Sen Li, Jiaxin Wang, Biao Zhang, Xinyi Li, Yuan Liu; Diabetes Metab J. 2019;43(3):319-341. Published online April 19, 2019; DOI: https://doi.org/10.4093/dmj.2018.0060
Cited By 99; Full text PubReader Crossref - TDM PDF Supplementary Material

Oral Glucose Tolerance Testing Allows Better Prediction of Diabetes in Women with a History of Gestational Diabetes Mellitus: Tae Jung Oh, Yeong Gi Kim, Sunyoung Kang, Joon Ho Moon, Soo Heon Kwak, Sung Hee Choi, Soo Lim, Kyong Soo Park, Hak C. Jang, Joon-Seok Hong, Nam H. Cho; Diabetes Metab J. 2019;43(3):342-349. Published online December 7, 2018; DOI: https://doi.org/10.4093/dmj.2018.0086
Cited By 9; Full text PubReader Crossref - TDM PDF

Association of Visit-to-Visit Variability of Blood Pressure with Cardiovascular Disease among Type 2 Diabetes Mellitus Patients: A Cohort Study: Zhe-Bin Yu, Die Li, Xue-Yu Chen, Pei-Wen Zheng, Hong-Bo Lin, Meng-Ling Tang, Ming-Juan Jin, Jian-Bing Wang, Kun Chen; Diabetes Metab J. 2019;43(3):350-367. Published online March 6, 2019; DOI: https://doi.org/10.4093/dmj.2018.0108
Cited By 11; Full text PubReader Crossref - TDM PDF Supplementary Material

Serum R-Spondin 1 Is a New Surrogate Marker for Obesity and Insulin Resistance: Yea Eun Kang, Ji Min Kim, Hyon-Seung Yi, Kyong Hye Joung, Ju Hee Lee, Hyun Jin Kim, Bon Jeong Ku; Diabetes Metab J. 2019;43(3):368-376. Published online October 23, 2018; DOI: https://doi.org/10.4093/dmj.2018.0066
Cited By 5; Full text PubReader Crossref - TDM PDF

Letter: Predictors of the Therapeutic Efficacy and Consideration of the Best Combination Therapy of Sodium-Glucose Co-transporter 2 Inhibitors (Diabetes Metab J 2019;43:158–73): Kyung-Soo Kim; Diabetes Metab J. 2019;43(3):377-378. Published online June 13, 2019; DOI: https://doi.org/10.4093/dmj.2018.0091; Full text PubReader Crossref - TDM PDF

Response: Predictors of the Therapeutic Efficacy and Consideration of the Best Combination Therapy of Sodium-Glucose Co-transporter 2 Inhibitors (Diabetes Metab J 2019;43:158–73): Ji-Yeon Lee, Eun Seok Kang; Diabetes Metab J. 2019;43(3):379-380. Published online June 13, 2019; DOI: https://doi.org/10.4093/dmj.2018.0106; Full text PubReader Crossref - TDM PDF

Corrigenda: Omission of the Description of Informed Consent: Diabetes Metab J. 2019;43(3):381-381. Published online June 13, 2019; DOI: https://doi.org/10.4093/dmj.2018.0100; Full text PubReader Crossref - TDM PDF

65,535	Comparison of Insulin-Treated Patients with Ambiguous Diabetes Type with Definite Type 1 and Type 2 Diabetes Mellitus Subjects: A Clinical Perspective
65,535	Sex Differences in the Effects of CDKAL1 Variants on Glycemic Control in Diabetic Patients: Findings from the Korean Genome and Epidemiology Study
65,535	Metabolic Dysfunction-Associated Fatty Liver Disease and Mortality: A Population-Based Cohort Study
15,995	2021 Clinical Practice Guidelines for Diabetes Mellitus in Korea
9,949	Insulin Resistance: From Mechanisms to Therapeutic Strategies

Cited By 122	Diabetes Fact Sheets in Korea, 2020: An Appraisal of Current Status
Cited By 83	2021 Clinical Practice Guidelines for Diabetes Mellitus in Korea
Cited By 48	Treatment of Diabetic Kidney Disease: Current and Future
Cited By 41	Insulin Resistance: From Mechanisms to Therapeutic Strategies
Cited By 37	Hyperinsulinemia in Obesity, Inflammation, and Cancer

Previous issues